A simple, sensitive, accurate and rapid spectrophotometric method has been developed for the estimation of cefotaxime and ceftriaxone using Folin-Ciocalteu reagent in presence of 20% sodium carbonate solution. The blue colour chromogen formed is measured at wavelength of maximum absorption 752 nm and 750 nm for cefotaxime and ceftriaxone respectively against reagent blank. The chromogen obeyed linearity over 5.0 to 60 µg/ml for cefotaxime, and 2.0 to 36 µg/ml for ceftriaxone. The results of analysis have been validated statistically and by recovery studies. and spectrophotometric methods [11] [12] [13] for its determination. Ceftriaxone is official in USP and BP but not official in IP. The USP 14 and BP 15 describe HPLC method for estimation of ceftriaxone. Literature survey reveals HPTLC 8 , HPLC 9 and spectrophotometric methods 11, 12 for its determination. The present communication describes a simple, sensitive, accurate, rapid and economical colorimetric method for the estimation of CFT and CFX in their dosage forms using Folin-Ciocalteu (FC) reagent in presence of 20% sodium carbonate solution.
A Shimadzu model 1601 double beam UV/Vis spectrophotometer with spectral width of 2 nm and wavelength accuracy of 0.5 nm and with a pair of 10 mm matched quartz cells was used to measure absorbance of the resulting solutions. A Sartorius CP224S analytical balance, an ultrasonic cleaner (Frontline FS 4), cefotaxime and ceftriaxone (Mann Pharmaceuticals Ltd., Mehsana), FC reagent (diluted to 1:4 with glass-distilled water), 20% sodium carbonate solution and double glass-distilled water were used in the study.
The standard stock solution of CFT and CFX were prepared by dissolving CFT and CFX, 10 mg of each, in 100 ml volumetric flask separately using glass-distilled water (100 µg/ml). Aliquots of 0.5 to 6.0 ml portions of standard solution of cefotaxime and 0.2 to 3.6 ml of ceftriaxone were transferred to a series of 10 ml corning volumetric flask. To each flask, 1 ml and 2 ml of 20% sodium carbonate solution with 1.5 ml and 3 ml of diluted FC reagent for cefotaxime and ceftriaxone respectively were added. After thoroughly shaking, the flasks were set aside for 10 min for the reaction to complete. The volumes of each flask were adjusted to 10 ml with glassdistilled water. The absorbance of solution in each flask was measures at 752 nm and 750 nm for cefotaxime and ceftriaxone, respectively against reagent blank.
An accurately weighed powder equivalent to 10 mg each of cefotaxime and ceftriaxone was transferred to separate 100 ml volumetric flasks. The content was dissolved in glass-distilled water and diluted up to the mark with glassdistilled water. These solutions were then analyzed, as described, under respective calibration curve procedure. The analysis procedure was repeated five times with pharmaceutical formulation and the result of analysis of pharmaceutical formulation is shown in Table 1 .
To study the accuracy and precision of the proposed method, recovery studies were carried out by addition of known amount of standard drug solution of CFT and CFX to pre-analyzed formulation. The resulting solution was then reanalyzed by proposed method. Results of recovery studies were found to be satisfactory and are reported in Table 1 .
In the present work, the quantitative reaction of the drug with FC reagent is proposed. The reaction is based on the reduction of phosphomolybdotungstic acid, the FC reagent, by cefotaxime and ceftriaxone in presence of 20% sodium carbonate solution, thereby producing reduced species having characteristic blue colour with maximum absorption at 752 nm and 750 nm respectively. It was found that 1.5 ml FC reagent with 1 ml 20% sodium carbonate solution for cefotaxime and 3 ml FC reagent with 1.5 ml 20% sodium carbonate solution for ceftriaxone was sufficient for the development of maximum colour intensity. Colored chromogen was found to be stable for more than 3 h at room temperature for both the drugs. The linearity was found in the concentration range of 5 to 60 µg/ml (r Table 2 .
In conclusion, the proposed method is new, simple, sensitive, accurate and precise and can be successfully employed for the routine analysis of these drugs in pharmaceutical dosage form (dry powder for injection). 
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